Aura Biosciences
AURA | NASDAQ
$7.22
+$0.11 (+1.55%)
At close: Nov 16, 2026, 4:00 PM ET
$7.22
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+1.55%
(1D)Rating
27
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #874/1021 (Top 86%)
Key Statistics
Market Data
Market Cap $801.95M
1D Range
7.00 7.30
52W Range
4.97 8.90
Valuation (TTM)
PE -4.32
PB 2.79
EV/EBITDA -3.69
Valuation (NTM)
Forward PE N/A
Forward PEG 0.19
Price Target $16.50
Cash Flow
FCF Yield -13.7%
SBC Adj. FCF Yield -16.7%
SBC Impact -22.2%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 1.7% |
5.6%
FCF 3Y | 5Y -19.3% |
-18.3%
Returns
ROA -42.6%
ROE -64.7%
ROIC -47.8%
Financial Health
Net Cash
$297.23M
Current Ratio 14.21
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary vi...
Sector Healthcare
Industry Biotechnology
Employees 113
IPO Date Oct 29, 2021
Website www.aurabiosciences.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$16.50
Upside
+128.53%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove AURA